Literature DB >> 21746738

Combination of micellar electrokinetic and high-performance liquid chromatographies to assess age-related changes in the in vitro metabolism of Fischer 344 rat liver.

Yaohua Wang1, Joseph B Katzenmeyer, Edgar A Arriaga.   

Abstract

The metabolism of doxorubicin, a widely used anticancer drug, is different in young adult and old cancer patients. In this study, we demonstrate that micellar electrokinetic chromatography with laser-induced fluorescence detection is highly suited to monitor the metabolism of doxorubicin in subcellular fractions isolated from young adult (11 months, 100% survival rate) and old (26 months, ~25% survival rate) Fischer 344 rat livers. The relative amounts of doxorubicin metabolized in both mitochondria-enriched and postmitochondria fractions of young adult were larger than the respective fractions of old rat liver. 7-Deoxydoxorubicinolone and 7-deoxydoxorubicinone were identified using internal standard addition and structural elucidation by high-performance liquid chromatography with combined laser-induced fluorescence and mass spectrometry detection. Although high-performance liquid chromatography with combined laser-induced fluorescence and mass spectrometry detection is more useful in the identification of compounds, micellar electrokinetic chromatography with laser-induced fluorescence detection has low-sample requirements, simplified sample processing procedures, short analysis times and low limit of detection. Therefore, the combination of these two techniques provides a powerful approach to investigate metabolism of fluorescent drugs in aging studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21746738      PMCID: PMC3202906          DOI: 10.1093/gerona/glr074

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  34 in total

1.  Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.

Authors:  Robert D Arnold; Jeanine E Slack; Robert M Straubinger
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-09-05       Impact factor: 3.205

2.  Pharmacokinetics of adriamycin, adriamycinol, and antipyrine in patients with moderate tumor involvement of the liver.

Authors:  R Preiss; M Matthias; R Sohr; B Brockmann; H Hüller
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

3.  Adriamycin metabolism in man. Evidence from urinary metabolites.

Authors:  S Takanashi; N R Bachur
Journal:  Drug Metab Dispos       Date:  1976 Jan-Feb       Impact factor: 3.922

4.  A study of some possible mechanisms by which magnesium activates hepatic microsomal drug metabolism in vitro.

Authors:  M A Peters; J R Fouts
Journal:  J Pharmacol Exp Ther       Date:  1970-06       Impact factor: 4.030

5.  Risk factors for doxorubicin-induced congestive heart failure.

Authors:  D D Von Hoff; M W Layard; P Basa; H L Davis; A L Von Hoff; M Rozencweig; F M Muggia
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

6.  Doxorubicin toxicity and pharmacokinetics in old and young rats.

Authors:  T Colombo; M G Donelli; R Urso; S Dallarda; I Bartosek; A Guaitani
Journal:  Exp Gerontol       Date:  1989       Impact factor: 4.032

7.  Age-associated accumulation of heat-labile aminoacyl-tRNA synthetases in mice and rats.

Authors:  R Takahashi; S Goto
Journal:  Arch Gerontol Geriatr       Date:  1987-04       Impact factor: 3.250

8.  Changes in some hepatic enzyme activities related to phase II drug metabolism in male and female rats as a function of age.

Authors:  C Santa Maria; A Machado
Journal:  Mech Ageing Dev       Date:  1988-08       Impact factor: 5.432

9.  Hepatic metabolism of doxorubicin in mice and rats.

Authors:  P Vrignaud; D Londos-Gagliardi; J Robert
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Apr-Jun       Impact factor: 2.441

10.  Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbit.

Authors:  D A Gewirtz; S Yanovich
Journal:  Biochem Pharmacol       Date:  1987-06-01       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.